These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 20889333)

  • 1. Molecular mechanisms of leptin and adiponectin in breast cancer.
    Jardé T; Perrier S; Vasson MP; Caldefie-Chézet F
    Eur J Cancer; 2011 Jan; 47(1):33-43. PubMed ID: 20889333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of disease: adipokines and breast cancer - endocrine and paracrine mechanisms that connect adiposity and breast cancer.
    Schäffler A; Schölmerich J; Buechler C
    Nat Clin Pract Endocrinol Metab; 2007 Apr; 3(4):345-54. PubMed ID: 17377617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-1 family in breast cancer: potential interplay with leptin and other adipocytokines.
    Perrier S; Caldefie-Chézet F; Vasson MP
    FEBS Lett; 2009 Jan; 583(2):259-65. PubMed ID: 19111549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.
    Jardé T; Caldefie-Chézet F; Goncalves-Mendes N; Mishellany F; Buechler C; Penault-Llorca F; Vasson MP
    Endocr Relat Cancer; 2009 Dec; 16(4):1197-210. PubMed ID: 19661131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of obesity on breast cancer development.
    Cleary MP; Grossmann ME; Ray A
    Vet Pathol; 2010 Mar; 47(2):202-13. PubMed ID: 20124008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression.
    Vona-Davis L; Rose DP
    Endocr Relat Cancer; 2007 Jun; 14(2):189-206. PubMed ID: 17639037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and breast cancer: status of leptin and adiponectin in pathological processes.
    Grossmann ME; Ray A; Nkhata KJ; Malakhov DA; Rogozina OP; Dogan S; Cleary MP
    Cancer Metastasis Rev; 2010 Dec; 29(4):641-53. PubMed ID: 20821253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer.
    Carroll PA; Healy L; Lysaght J; Boyle T; Reynolds JV; Kennedy MJ; Pidgeon G; Connolly EM
    Mol Carcinog; 2011 Aug; 50(8):643-51. PubMed ID: 21574190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer.
    Arditi JD; Venihaki M; Karalis KP; Chrousos GP
    Horm Metab Res; 2007 Jan; 39(1):9-13. PubMed ID: 17226107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity.
    Stofkova A
    Endocr Regul; 2009 Oct; 43(4):157-68. PubMed ID: 19908934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells.
    Dos Santos E; Benaitreau D; Dieudonne MN; Leneveu MC; Serazin V; Giudicelli Y; Pecquery R
    Oncol Rep; 2008 Oct; 20(4):971-7. PubMed ID: 18813842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy balance adiposity and breast cancer - energy restriction strategies for breast cancer prevention.
    Harvie M; Howell A
    Obes Rev; 2006 Feb; 7(1):33-47. PubMed ID: 16436101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin as a potential therapeutic target for breast cancer prevention and treatment.
    Ray A; Cleary MP
    Expert Opin Ther Targets; 2010 Apr; 14(4):443-51. PubMed ID: 20230196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, leptin, and adiponectin receptors in colon: regulation relative to differing body adiposity independent of diet and in response to dimethylhydrazine.
    Drew JE; Farquharson AJ; Padidar S; Duthie GG; Mercer JG; Arthur JR; Morrice PC; Barrera LN
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G682-91. PubMed ID: 17656443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into anticarcinogenic properties of adiponectin: a potential therapeutic approach in breast cancer?
    Delort L; Jardé T; Dubois V; Vasson MP; Caldefie-Chézet F
    Vitam Horm; 2012; 90():397-417. PubMed ID: 23017724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adipokines in complications related to obesity: a review.
    Gnacińska M; Małgorzewicz S; Stojek M; Łysiak-Szydłowska W; Sworczak K
    Adv Med Sci; 2009; 54(2):150-7. PubMed ID: 19875356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of adiponectin receptors and the effects of adiponectin and leptin on airway smooth muscle cells.
    Shin JH; Kim JH; Lee WY; Shim JY
    Yonsei Med J; 2008 Oct; 49(5):804-10. PubMed ID: 18972601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects.
    Ashizawa N; Yahata T; Quan J; Adachi S; Yoshihara K; Tanaka K
    Gynecol Oncol; 2010 Oct; 119(1):65-9. PubMed ID: 20674961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leptin and leptin receptor involvement in cancer development: a study on human primary breast carcinoma.
    Jardé T; Caldefie-Chézet F; Damez M; Mishellany F; Penault-Llorca F; Guillot J; Vasson MP
    Oncol Rep; 2008 Apr; 19(4):905-11. PubMed ID: 18357374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.